Valuation Compugen Ltd. TEL AVIV STOCK EXCHANGE
Stocks
CGEN
IL0010852080
Biotechnology & Medical Research
|
Market Closed -
TEL AVIV STOCK EXCHANGE
06:44:26 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 813.00 ILa | -0.40% |
|
+4.12% | +73.72% |
| 08-03 | Compugen Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-03 | Compugen Ltd., Q2 2026 Earnings Call, Aug 03, 2026 |
Company Valuation: Compugen Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 370.7 | 62 | 174.9 | 137 | 143.1 | 246.3 | - | - |
| Change | - | -83.28% | 182.09% | -21.67% | 4.47% | 72.09% | - | - |
| Enterprise Value (EV) | 370.7 | 62 | 174.9 | 137 | 143.1 | 246.3 | 246.3 | 246.3 |
| Change | - | -83.28% | 182.09% | -21.67% | 4.47% | 72.09% | 0% | 0% |
| P/E | -10.5x | -1.84x | -9.43x | -9.56x | 4.03x | -9.29x | -9.42x | -9.77x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.38x | 0.2x | 0.4x | -0x | 0x | 6.59x | 2.7x |
| Capitalization / Revenue | 61.8x | 8.27x | 5.23x | 4.92x | 1.97x | 26.7x | 31.8x | 13.7x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 26.7x | 31.8x | 13.7x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | 0x | -8.22x | -8.93x | -8.44x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.41 | -0.39 | -0.21 | -0.16 | 0.38 | -0.28 | -0.276 | -0.266 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 6 | 7.5 | 33.46 | 27.86 | 72.76 | 9.239 | 7.75 | 18.02 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | -35.07 | -35.37 | -12.99 | -14.89 | 31.33 | -29.97 | -27.58 | -29.19 |
| Net income 1 | -34.2 | -33.69 | -18.75 | -14.23 | 35.34 | -26.46 | -26.95 | -26.63 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 4.300 | 0.716 | 1.980 | 1.530 | 1.530 | 2.600 | 2.600 | 2.600 |
| Nbr of stocks (in thousands) | 86,214 | 86,625 | 88,327 | 89,536 | 93,535 | 94,724 | - | - |
| Announcement Date | 2/24/22 | 2/27/23 | 3/5/24 | 3/4/25 | 3/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 34.28x | 6.11x | 18.18x | 0.94% | 50.47B | |
| -21.19x | 258.61x | -22.63x | -.--% | 44.56B | |
| 33.71x | 3.27x | 14.1x | -.--% | 43.08B | |
| 48.04x | 5.57x | 30.46x | -.--% | 41.7B | |
| 28.96x | 8.75x | 22.11x | 0.4% | 33.21B | |
| 34.16x | 5.6x | 25.43x | -.--% | 16.77B | |
| 24.12x | 2.1x | 9.08x | 1.12% | 14.58B | |
| 77.98x | 4.1x | 15.89x | -.--% | 13.92B | |
| Average | 32.51x | 36.76x | 14.08x | 0.31% | 32.28B | |
| Weighted average by Cap. | 27.93x | 49.08x | 12.78x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CGEN Stock
- CGEN Stock
- Valuation Compugen Ltd.
Select your edition
All financial news and data tailored to specific country editions
